Related Experiment Video

Updated: Aug 17, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C

Adam Gordon1, Michael J Bailey, Peter R Gibson

  • 1Department of Gastroenterology, Alfred Hospital, Commercial Road, Prahran, Victoria 3181, Australia.

Journal of Gastroenterology and Hepatology
|June 11, 2005
PubMed

Insights

A comprehensive clinical assessment combining clinical markers, the discriminant score, and serum hyaluronic acid accurately predicts cirrhosis in chronic hepatitis C patients, offering a non-invasive diagnostic alternative.

Area of Science:

  • Hepatology
  • Clinical Diagnostics
  • Biomarker Research

Background:

  • Diagnosing cirrhosis in chronic hepatitis C (CHC) is crucial but challenging without liver biopsy.
  • Non-invasive methods are needed to assess liver fibrosis in CHC patients.

Purpose of the Study:

  • To compare the predictive accuracy of individual clinical markers, the discriminant score (DS), and serum hyaluronic acid (HA) for cirrhosis in CHC.
  • To evaluate the combined performance of these markers in predicting cirrhosis.

Main Methods:

  • Retrospective analysis of 151 CHC patients undergoing liver biopsy.
  • Development and validation of a clinical examination score (CES), calculation of DS, and assay of serum HA.
  • Construction of combination scores integrating CES, DS, and serum HA score (HAS).

Main Results:

  • Serum HA demonstrated higher accuracy than CES or DS alone in predicting cirrhosis.
  • The combination of CES, DS, and HAS achieved the highest accuracy, with 78% sensitivity and 93% specificity.
  • Positive and negative predictive values for the combined score were 75% and 94%, respectively.

Conclusions:

  • A comprehensive clinical assessment using combined clinical and laboratory data offers superior prediction of cirrhosis in CHC compared to individual markers.
  • This integrated approach provides a more accurate, non-invasive method for diagnosing cirrhosis in CHC patients.
Abstract

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: